Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1997 | 2 |
1999 | 1 |
2005 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection.
J Clin Invest. 2005 Sep;115(9):2444-53. doi: 10.1172/JCI25208. Epub 2005 Aug 25.
J Clin Invest. 2005.
PMID: 16127466
Free PMC article.
Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9.
He C, Imai M, Song H, Quigg RJ, Tomlinson S.
He C, et al.
J Immunol. 2005 May 1;174(9):5750-7. doi: 10.4049/jimmunol.174.9.5750.
J Immunol. 2005.
PMID: 15843577
Item in Clipboard
Protection of human breast cancer cells from complement-mediated lysis by expression of heterologous CD59.
Yu J, Caragine T, Chen S, Morgan BP, Frey AB, Tomlinson S.
Yu J, et al.
Clin Exp Immunol. 1999 Jan;115(1):13-8. doi: 10.1046/j.1365-2249.1999.00751.x.
Clin Exp Immunol. 1999.
PMID: 9933415
Free PMC article.
Item in Clipboard
Human alternative complement pathway-mediated lysis of rabbit erythrocytes is enhanced by natural anti-Galalpha1-3Gal antibodies.
Tomlinson S, Nussenzweig V.
Tomlinson S, et al.
J Immunol. 1997 Dec 1;159(11):5606-9.
J Immunol. 1997.
PMID: 9548503
Item in Clipboard
Mapping the active site of CD59.
Yu J, Abagyan R, Dong S, Gilbert A, Nussenzweig V, Tomlinson S.
Yu J, et al.
J Exp Med. 1997 Feb 17;185(4):745-53. doi: 10.1084/jem.185.4.745.
J Exp Med. 1997.
PMID: 9034152
Free PMC article.
Item in Clipboard
Cite
Cite